首页 | 本学科首页   官方微博 | 高级检索  
   检索      


MELATONIN: DEACETYLATION TO 5-METHOXYTRYPTAMINE BY LIVER BUT NOT BRAIN ARYL ACYLAMIDASE
Authors:Michael A  Rogawski  Robert H  Roth George K  Aghajanian
Institution:Departments of Pharmacology and Psychiatry, Yale University School of Medicine and the Connecticut Mental Health Center, New Haven, CT 06510, U.S.A.
Abstract:Abstract— Rat liver and brain slices were incubated in vitro with 3H]melatonin. Liver slices synthesized small amounts of 3H]5-methoxyindoleacetic acid (3H]5-MIAA) along with other melatonin metabolites including 6-hydroxymelatonin. Pretreatment of animals prior to killing with the irreversible monoamine oxidase inhibitor pargyline allowed 3H]5-methoxytryptamine (3H]5-MT) to be recovered from the incubation. No 3H]5-MIAA or 3H]5-MT could be detected in incubations with hypothalamic slices or following intraventrieular injection of 3H]melatonin. The possibility that the deacetylase aryl acylamidase was in part responsible for the deacetylation occurring in liver slices was examined. Liver aryl acylamidase was able to utilize 3H]melatonin as substrate to produce 3H]5-MT. Furthermore, the liver enzyme was inhibited by melatonin ( Ki. 1 m m ) when tested with the alternate substrate o -nitroacetanalide. Brain aryl acylamidase did not generate any detectable 3H]5-MT nor was it inhibited by melatonin. These results suggest that 5-MT is not formed in brain from melatonin although trace amounts of 5-MT in the periphery could be derived from this precursor.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号